Clover Health Investments Corp’s recently made public that its Officer JAMIE REYNOSO acquired Company’s shares for reported $18968.0 on Aug 04 ’25. In the deal valued at $2.78 per share,6,823 shares were bought.
Then, Wai Conrad sold 118,600 shares, generating $390,194 in total proceeds. Upon selling the shares at $3.29, the CEO, Counterpart Health now owns 1,494,898 shares.
Before that, Wai Conrad sold 91,197 shares. Clover Health Investments Corp shares valued at $302,774 were divested by the CEO, Counterpart Health at a price of $3.32 per share. As a result of the transaction, Wai Conrad now holds 1,403,701 shares, worth roughly $4.0 million.
Craig Hallum initiated its Clover Health Investments Corp [CLOV] rating to a Buy in a research note published on December 17, 2024; the price target was $6. A number of analysts have revised their coverage, including UBS’s analysts, who began to cover the stock in early October with a ‘”a Neutral”‘ rating. Cowen also remained covering CLOV and has increased its forecast on February 02, 2022 with a “Market perform” recommendation from previously “an Underperform” rating. Canaccord Genuity started covering the stock on February 02, 2022. It rated CLOV as “a Buy”.
Price Performance Review of CLOV
On Tuesday, Clover Health Investments Corp [NASDAQ:CLOV] saw its stock fall -1.04% to $2.85. Over the last five days, the stock has lost -1.38%. Clover Health Investments Corp shares have risen nearly 58.33% since the year began. Nevertheless, the stocks have fallen -9.52% over the past one year.
How much short interest is there in Clover Health Investments Corp?
A steep rise in short interest was recorded in Clover Health Investments Corp stocks on 2025-07-15, growing by 13.92 million shares to a total of 36.2 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-13 was 22.28 million shares. There was a rise of 38.45%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on January 19, 2022 when SVB Leerink began covering the stock and recommended ‘”a Mkt perform”‘ rating along with a $3 price target.
